m+Medelevator.RU
← Поиск публикаций
Advanced healthcare materials · 2026

Silk Fibroin-Modified Metal Organic Framework Acid-Controlled Release Nanocarrier for Polyetheretherketone to Combat Implant-Associated Infections and Promote Angiogenesis.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Su Yadi, Wang Junqi, Gong Heyi, Han Xiao, Wang Yu, Liu Yue, Chen Wanqiu, Ma Sihan, Zhao Jinghui

Аннотация

Polyetheretherketone (PEEK) has been regarded as a prospective alternative orthopedic implant, because of its elastic modulus approximately equal to human cortical bone. However, the poor antibacterial and angiogenic properties of bioinert PEEK have become a limitation to its clinical application. Therefore, a biomimetic metal organic framework acid-controlled release nanocarrier consisting of Zeolitic Imidazolate Framework-8 (ZIF-8) nanoparticles loaded with gentamicin and modified with silk fibroin nanospheres for PEEK implants is prepared. In this study, acidity-responsive PEEK implant can efficiently capture bacteria and eradicate bacterial biofilms, achieving antibacterial rates up to 99.9% against Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli). Furthermore, acidity-responsive PEEK implant is expected to promote angiogenesis by assisting proliferation and migration of endothelial cells, thereby accelerating peri-implant tissue regeneration. By constructing subcutaneous infection models, it is further indicated that acidity-responsive implant can resist bacterial proliferation and facilitate peri-implant angiogenesis. In summary, this study provided an effective approach for the improvement of orthopedic implants that realized antibacterial and angiogenic effects, offering a potential solution for preventing infection and promoting angiogenesis during the early phase after implantation.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты